Overview
Clinical Meaning
Diagnosing cirrhosis has evolved from mandatory liver biopsy (Metavir F4) to validated non invasive methods.
AGPCNP
AGPCNP
Diagnosing cirrhosis has evolved from mandatory liver biopsy (Metavir F4) to validated non-invasive methods. FibroScan (transient elastography) measures liver stiffness using ultrasound-based shear wave velocity: <7 kPa is normal, 7-12.5 kPa suggests significant fibrosis, >12.5 kPa suggests cirrhosis (with >95% NPV for ruling out advanced fibrosis). Serum biomarker panels include FIB-4 (combining age, AST, ALT, platelets; >3.25 suggests advanced fibrosis), APRI (AST-to-platelet ratio index), and enhanced liver fibrosis (ELF) test. The Child-Pugh classification (A=5-6, B=7-9, C=10-15) uses bilirubin, albumin, INR, ascites, and encephalopathy to stage functional severity. The MELD score (using bilirubin, INR, creatinine) predicts 3-month mortality and determines transplant priority.
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this AGPCNP pathway. You can still explore topic-filtered questions from the bank hubs below.